Catalyst Wire Dossier Catalyst Wire Dossier

Ledipasvir/Sofosbuvir + Ribavirin

ledipasvir/sofosbuvir with ribavirin · Gilead Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ledipasvir/Sofosbuvir + Ribavirin, covering 2014-11-26 to 2014-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection [Phase 3]

See pricing